In ASCVD, an inclisiran-first strategy reduced LDL-C levels and statin discontinuation at 330 d.
Where this comes from
- Record sourced from PubMed, PMID 39102716.
- Also identified by DOI 10.7326/ANNALS-24-01206-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Koren MJ, Rodriguez F, East C, et al. <b>An "inclisiran first" strategy vs usual care in patients with atherosclerotic cardiovascular disease.</b> J Am Coll Cardiol. 2024;83:1939-1952. 38593947.
Medical subject headings
- Cholesterol, LDL
- Hydroxymethylglutaryl-CoA Reductase Inhibitors